Prognosis and complete remission rate of diffuse large B‐cell lymphoma patients in standard R‐CHOP with reduction of vincristine: A retrospective study

Background and Aims The effect of stopping or reducing the dose of vincristine in diffuse large B‐cell lymphoma (DLBCL) on the outcome and prognosis of the disease is still in doubt. The present study aimed to investigate and compare the prognosis and complete remission of two R‐CHOP treatment regim...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Health science reports Ročník 6; číslo 12; s. e1716 - n/a
Hlavní autoři:	Riasi, Fatemeh, Ataei Azimi, Sajjad, Allahyari, Abolghasem, Moeini Nodeh, Mohammad, Shakeri, Mohammad T., Kamandi, Mostafa
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States John Wiley & Sons, Inc 01.12.2023 John Wiley and Sons Inc Wiley
Témata:	Age Chemotherapy Dehydrogenases DLBCL Drug dosages Hematology Lymphoma Medical prognosis Medical records Original Research Peripheral neuropathy prognosis Radiation Remission (Medicine) R‐CHOP Survival analysis Toxicity vincristine DLBCL R‐CHOP vincristine prognosis
ISSN:	2398-8835, 2398-8835
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!